Matrubials
YC S21Davis, US · Founded 2018 · 4 employees · 1 known investors
Matrubials develops antimicrobial peptides derived from milk to create novel therapeutics for bacterial infections, starting with bacterial vaginosis. The company uses AI-enabled technology to identify and validate bioactive molecules for infectious disease treatments.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryWomen's HealthTherapeuticsin /89732317/admin/feed/posts/@davidamills
Founders & leadership· Y Combinator alumni (S21)
Investors · 1
In the news
- NorCal AngelCon invests $150K in startups Strived.io, IntelliVasc - Sacramento Business Journalarchive.is · 2025
- Matrubials Inc. awarded a competitive NIH SBIR grantmatrubials.com · 2022
- Matrubials Inc. wins the Sacramento Business Journal's Innovation awardbizjournals.com · 2021
- Matrubials aims to turn a mother's milk into medicine - The Business Journalsbizjournals.com · 2021
- Matrubials - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021